Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA
Arlin Rogers is Director of Pathology in the Department of Early Development at Alnylam Pharmaceuticals. He directs the Investigative Pathology unit charged with identifying novel molecular targets and mitigating off-target toxicity associated with RNAi therapeutics. Additionally, he assists with safety and regulatory readouts for late-stage preclinical compounds. He received his DVM from the University of Illinois, and spent three years practicing small animal and emergency medicine in Houston and Austin, Texas.
Journal of Cytology & Histology received 2476 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 